文献速递糖尿病肥胖与代谢综合征性腺与生殖内分泌

瘦/超重胰岛素抵抗女性的代谢组学揭示类固醇与脂肪酸改变

Metabolomics of Lean/Overweight Insulin-Resistant Females Reveals Alterations in Steroids and Fatty Acids.
PubMed 文献 · J Clin Endocrinol Metab · 2021-01-01

该横断面研究比较了200名表观健康年轻女性(100例胰岛素抵抗、100例胰岛素敏感)的代谢组学特征,发现胰岛素抵抗者雄激素类固醇和微生物代谢物升高,而长链脂肪酸降低。基于20种代谢物的模型对胰岛素抵抗的判别性能优于传统临床指标(AUC 0.93 vs 0.73)。

要点

  • 胰岛素抵抗女性雄激素类固醇(如雄酮葡萄糖苷酸)和微生物代谢物升高。
  • 胰岛素敏感女性长链脂肪酸水平升高。
  • 20种代谢物组合对胰岛素抵抗的判别优于传统临床特征。

核心结论

  • 胰岛素抵抗具有多因素机制,涉及类固醇、长链脂肪酸和微生物代谢物等潜在生物标志物。

研究设计与样本

  • 横断面研究,从卡塔尔生物样本库纳入200名表观健康年轻女性,其中100例胰岛素抵抗、100例胰岛素敏感。

主要发现

  • 与胰岛素敏感者相比,胰岛素抵抗者雄激素类固醇(包括雄酮葡萄糖苷酸)及微生物代谢物(如苯丙氨酸衍生物羧乙基苯丙氨酸)升高。
  • 胰岛素敏感者长链脂肪酸水平升高。
  • GLMNET筛选的20种代谢物ROC分析AUC为0.93,传统临床特征AUC为0.73。

关键数值与推荐

  • ROC分析中20种代谢物AUC为0.93,传统临床特征AUC为0.73。

临床怎么用

  • 代谢组学标志物可能辅助识别瘦/超重女性的胰岛素抵抗,但需进一步验证。

局限性

  • 横断面设计无法推断因果关系。
  • 研究人群为年轻女性,结果外推需谨慎。
  • 发现的标志物需进一步研究验证其诊断和治疗应用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The global diabetes epidemic is largely attributed to obesity-triggered metabolic syndrome. However, the impact of insulin resistance (IR) prior to obesity on the high prevalence of diabetes and the molecular mediators remain largely unknown. This study aims to compare the metabolic profiling of apparently healthy lean/overweight participants with IR and insulin sensitivity (IS), and identify the metabolic pathways underlying IR. METHODS: In this cross-sectional study, clinical and metabolic data for 200 seemingly healthy young female participants (100 IR and 100 IS) was collected from Qatar Biobank. Orthogonal partial least square analysis was performed to assess the extent of separation between individuals from the 2 groups based on measured metabolites. Classical linear models were used to identify the metabolic signature of IR, followed by elastic-net-regularized generalized linear model (GLMNET) and receiver operating characteristic (ROC) analysis to determine top metabolites associated with IR. RESULTS: Compared to lean/overweight participants with IS, those with IR showed increased androgenic steroids, including androsterone glucuronide, in addition to various microbiota byproducts, such as the phenylalanine derivative carboxyethylphenylalanine. On the other hand, participants with IS had elevated levels of long-chain fatty acids. A ROC analysis suggested better discriminatory performance using 20 metabolites selected by GLMNET in comparison to the classical clinical traits (area under curve: 0.93 vs 0.73, respectively). CONCLUSION: Our data confirm the multifactorial mechanism of IR with a diverse spectrum of emerging potential biomarkers, including steroids, long-chain fatty acids, and microbiota metabolites. Further studies are warranted to validate these markers for diagnostic and therapeutic applications.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Diboun I, Al-Mansoori L, Al-Jaber H, et al. Metabolomics of Lean/Overweight Insulin-Resistant Females Reveals Alterations in Steroids and Fatty Acids. J Clin Endocrinol Metab. 2021. PMID: 33053159. doi:10.1210/clinem/dgaa732

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。